Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07247409

Establishment of Hong Kong Diabesity Register

All participants of the Diabesity Register will receive structured assessment by nurses guided by the JADE portal at baseline including eye, feet, blood and urine examination with evaluation of BMI, blood pressure, HbA1c, lipid profile, renal and liver function tests, urine for albumin-creatinine ratio. All patients will return at 3-year for a repeat assessment of physical and psychological health, as well as changes over time.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Diabesity Body Weight Diabetes Complications Diabetes Mellitus Endocrine System Diseases Obesity Overweight Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Medicine and Therapeutics, The Chinese University of Hong Kong (CUHK), Ward 3M, Diabetes and Endocrine Research Centre, 3/F Day Treatment Block and Children Wards (Old Block), Prince of Wales Hospital

Hong Kong

Location status: Recruiting

Location contact

Alice Pik Shan Kong, MD

CONTACT

[email protected]

+852 3505 2648

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Type 2 diabetes;
  • Obesity reaching action level as defined as body mass index (BMI) 27.5 kg/m2 and/or waist circumference (WC) 80cm in women and 90cm in men;
  • Age between 18 and 50 years;
  • Able to conversate with smartphone technology and web-based program.
  • Able to read Chinese and communicate using Chinese.

Exclusion criteria

  • Type 1 diabetes;
  • Active malignant disease including those with history of malignant disease less than 5 years of disease-free duration;
  • Life expectancy less than 12 months;
  • Any medical illness or condition as judged by the investigators as ineligible to participate the study.

Treatment and study plan

No Intervention: Observational Cohort

Other

It is an registry so no intervention will be used.

Primary outcomes

  1. A composite of incidence

    Time frame: 3 years

    Incidence of diabetes-related complications

Secondary outcomes

  1. Incidence of diabetic mellitus retinopathy

    Time frame: 3 years

  2. Incidence of diabetic mellitus nephropathy

    Time frame: 3 years

  3. Incidence of diabetic mellitus neuropathy

    Time frame: 3 years

  4. Incidence of myocardial infarction

    Time frame: 3 years

  5. Incidence of stroke

    Time frame: 3 years

  6. Incidence of peripheral artery disease

    Time frame: 3 years

Study contacts

Contact information is provided by the study sponsor or research team.

Alice Pik Shan Kong, MD

CONTACT

[email protected]

+852 3505 2648

Sponsors and collaborators

Lead sponsor

Chinese University of Hong Kong

Other

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2029
First posted
Nov 25, 2025
Registry last updated
Nov 25, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.